← FDA Drug Approvals (Drugs@FDA)

TIMENTIN

NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 1985-04-01

Drug application

FDA Application #

NDA050590

Application type

New Drug Application

Brand name

TIMENTIN

Generic name

Clavulanate Potassium

Active ingredients

CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

GLAXOSMITHKLINE

First approval

1985-04-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown